Search

Displaying results 8901 - 8910 of 10000 in total
  1. Drug

    Rhenium re-186

    go.drugbank.com/drugs/DB19266
    Investigational

    Rhenium re-186 is under investigation in clinical trial NCT01906385 (Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (Respect)).

  2. Drug

    ATR-04

    go.drugbank.com/drugs/DB26782
    Investigational

    ATR-04 is a biologic drug. ATR-04 is under investigation in clinical trial NCT04731259 (Study to Evaluate the Safety of ATR-04).

  3. Drug

    UK-390957

    go.drugbank.com/drugs/DB11719
    Investigational

    UK-390,957 has been used in trials studying the treatment of Ejaculation.

  4. Drug

    Gaxilose

    go.drugbank.com/drugs/DB12767
    ApprovedWithdrawn

    Gaxilose has been used in trials studying the diagnostic of Lactose Intolerance.

  5. Drug

    Liafensine

    go.drugbank.com/drugs/DB14878
    Investigational

    Liafensine is under investigation in clinical trial NCT00892840 (Multiple-Ascending Dose Study).

  6. Drug

    Pegapamodutide

    go.drugbank.com/drugs/DB14817
    Investigational

    Pegapamodutide is under investigation in clinical trial NCT02188303 (A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants).

  7. Drug

    Icrucumab

    go.drugbank.com/drugs/DB14824
    Investigational

    Icrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).

  8. Drug

    PF-5190457

    go.drugbank.com/drugs/DB14870
    Investigational

    PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations In Healthy Volunteers).

  9. Drug

    Pimitespib

    go.drugbank.com/drugs/DB14876
    Investigational

    TAS-116 is under investigation in clinical trial NCT02965885 (A Study of TAS-116 in Patients With Solid Tumors).

  10. Drug

    GI heptapeptide

    go.drugbank.com/drugs/DB15070
    Investigational

    GI heptapeptide is under investigation in clinical trial NCT01391208 (Esophageal Protocol for Detection of Neoplasia in the Digestive Tract).